Citations (60)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Yong-Jiang Li, Jun-Yong Wu, Jihua Liu, Xiaohan Qiu, Wenjie Xu, Tiantian Tang & Da-Xiong Xiang. (2021) From blood to brain: blood cell-based biomimetic drug delivery systems. Drug Delivery 28:1, pages 1214-1225.
Read now
Read now
Subramaniyan Manibalan, Kandasamy Thirukumaran, Mathimaran Varshni, Ayyasamy Shobana & Anant Achary. (2020) Report on biopharmaceutical profile of recent biotherapeutics and insilco docking studies on target bindings of known aptamer biotherapeutics. Biotechnology and Genetic Engineering Reviews 36:2, pages 57-80.
Read now
Read now
Tatsunori Takahashi, Sakai Noriaki, Mari Matsumura, Chenyu Li, Kayo Takahashi & Seiji Nishino. (2018) Advances in pharmaceutical treatment options for narcolepsy. Expert Opinion on Orphan Drugs 6:10, pages 597-610.
Read now
Read now
Shinichi Takenoshita, Noriaki Sakai, Yuhei Chiba, Mari Matsumura, Mai Yamaguchi & Seiji Nishino. (2018) An overview of hypocretin based therapy in narcolepsy. Expert Opinion on Investigational Drugs 27:4, pages 389-406.
Read now
Read now
Flavia Maria Sutera, Viviana De Caro & Libero Italo Giannola. (2017) Small endogenous molecules as moiety to improve targeting of CNS drugs. Expert Opinion on Drug Delivery 14:1, pages 93-107.
Read now
Read now
Articles from other publishers (55)
Daria A. Chudakova, Ekaterina M. Samoilova, Vladimir P. Chekhonin & Vladimir P. Baklaushev. (2023) Improving Efficiency of Direct Pro-Neural Reprogramming: Much-Needed Aid for Neuroregeneration in Spinal Cord Injury. Cells 12:20, pages 2499.
Crossref
Crossref
Christopher T. Bolden, Max A. Skibber, Scott D. Olson, Miriam Zamorano Rojas, Samantha Milewicz, Brijesh S. Gill & Charles S. CoxJrJr. (2023) Validation and characterization of a novel blood–brain barrier platform for investigating traumatic brain injury. Scientific Reports 13:1.
Crossref
Crossref
Anna Jezierski, Jez Huang, Arsalan S. Haqqani, Julie Haukenfrers, Ziying Liu, Ewa Baumann, Caroline Sodja, Claudie Charlebois, Christie E. Delaney, Alexandra T. Star, Qing Liu & Danica B. Stanimirovic. (2023) Mouse embryonic stem cell-derived blood–brain barrier model: applicability to studying antibody triggered receptor mediated transcytosis. Fluids and Barriers of the CNS 20:1.
Crossref
Crossref
Wandong Zhang, Qing Yan Liu, Arsalan S. Haqqani, Ziying Liu, Caroline Sodja, Sonia Leclerc, Ewa Baumann, Christie E. Delaney, Eric Brunette & Danica B. Stanimirovic. (2023) Differential Expression of ABC Transporter Genes in Brain Vessels vs. Peripheral Tissues and Vessels from Human, Mouse and Rat. Pharmaceutics 15:5, pages 1563.
Crossref
Crossref
Jacob Kaiserman, Bethany A. O’Hara, Sheila A. Haley & Walter J. Atwood. (2023) An Elusive Target: Inhibitors of JC Polyomavirus Infection and Their Development as Therapeutics for the Treatment of Progressive Multifocal Leukoencephalopathy. International Journal of Molecular Sciences 24:10, pages 8580.
Crossref
Crossref
Alexandre Pérez-López, Ana Isabel Torres-Suárez, Cristina Martín-Sabroso & Juan Aparicio-Blanco. (2023) An overview of in vitro 3D models of the blood-brain barrier as a tool to predict the in vivo permeability of nanomedicines. Advanced Drug Delivery Reviews 196, pages 114816.
Crossref
Crossref
Amira Sayed Hanafy, Pia Steinlein, Julika Pitsch, Mariella Hurtado Silva, Natascha Vana, Albert J. Becker, Mark Evan Graham, Susanne Schoch, Alf Lamprecht & Dirk Dietrich. (2023) Subcellular analysis of blood-brain barrier function by micro-impalement of vessels in acute brain slices. Nature Communications 14:1.
Crossref
Crossref
Tanja Ilić, Jelena B. Đoković, Ines Nikolić, Jelena R. Mitrović, Ivana Pantelić, Snežana D. Savić & Miroslav M. Savić. (2023) Parenteral Lipid-Based Nanoparticles for CNS Disorders: Integrating Various Facets of Preclinical Evaluation towards More Effective Clinical Translation. Pharmaceutics 15:2, pages 443.
Crossref
Crossref
Céline Cegarra, C. Chaves, C. Déon, T. M. Do, B. Dumas, A. Frenzel, P. Kuhn, V. Roudieres, J. C. Guillemot & D. Lesuisse. (2022) Exploring ITM2A as a new potential target for brain delivery. Fluids and Barriers of the CNS 19:1.
Crossref
Crossref
Shiran Su, Thomas J. Esparza & David L. Brody. (2022) Selection of single domain anti-transferrin receptor antibodies for blood-brain barrier transcytosis using a neurotensin based assay and histological assessment of target engagement in a mouse model of Alzheimer’s related amyloid-beta pathology. PLOS ONE 17:10, pages e0276107.
Crossref
Crossref
Céline Cegarra, Béatrice Cameron, Catarina Chaves, Tarik Dabdoubi, Tuan-Minh Do, Bruno Genêt, Valérie Roudières, Yi Shi, Patricia Tchepikoff & Dominique Lesuisse. (2022) An innovative strategy to identify new targets for delivering antibodies to the brain has led to the exploration of the integrin family. PLOS ONE 17:9, pages e0274667.
Crossref
Crossref
Elizabeth C. M. de Lange & Margareta Hammarlund Udenaes. (2022) Understanding the Blood‐Brain Barrier and Beyond: Challenges and Opportunities for Novel CNS Therapeutics. Clinical Pharmacology & Therapeutics 111:4, pages 758-773.
Crossref
Crossref
Snehal Raut, Aditya Bhalerao, Behnam Noorani & Luca Cucullo. 2022. The Blood-Brain Barrier. The Blood-Brain Barrier
25
49
.
Caroline Sodja, Deborah Callaghan, Arsalan S. Haqqani, Danica B. Stanimirovic, Willard J. Costain & Anna Jezierski. 2022. Induced Pluripotent Stem Cells and Human Disease. Induced Pluripotent Stem Cells and Human Disease
345
357
.
Amira Sayed Hanafy, Dirk Dietrich, Gert Fricker & Alf Lamprecht. (2021) Blood-brain barrier models: Rationale for selection. Advanced Drug Delivery Reviews 176, pages 113859.
Crossref
Crossref
Keita Kitamura, Kenta Umehara, Ryo ItoYoshiyuki YamauraTakafumi KomoriHanae Morio, Hidetaka Akita & Tomomi Furihata. (2021) Development, Characterization and Potential Applications of a Multicellular Spheroidal Human Blood–Brain Barrier Model Integrating Three Conditionally Immortalized Cell Lines. Biological and Pharmaceutical Bulletin 44:7, pages 984-991.
Crossref
Crossref
Hongyan Zhang, Tomoko Yamaguchi & Kenji Kawabata. 2021. Recent Advances in iPSC Technology. Recent Advances in iPSC Technology
63
85
.
Claudie Charlebois, Jez Huang, Caroline Sodja, Maria Ribecco-Lutkiewicz, Ewa Baumann, Danica B. Stanimirovic & Anna Jezierski. 2022. Induced Pluripotent Stem (iPS) Cells. Induced Pluripotent Stem (iPS) Cells
397
410
.
Vladimir Gubala, Giorgia Giovannini, Filip Kunc, Marco P. Monopoli & Colin J. Moore. (2020) Dye-doped silica nanoparticles: synthesis, surface chemistry and bioapplications. Cancer Nanotechnology 11:1.
Crossref
Crossref
Moriah E Katt & Eric V Shusta. (2020) In vitro models of the blood-brain barrier: building in physiological complexity. Current Opinion in Chemical Engineering 30, pages 42-52.
Crossref
Crossref
Antje Appelt‐Menzel, Sabrina Oerter, Sanjana Mathew, Undine Haferkamp, Carla Hartmann, Matthias Jung, Winfried Neuhaus & Ole Pless. (2020) Human iPSC‐Derived Blood‐Brain Barrier Models: Valuable Tools for Preclinical Drug Discovery and Development?. Current Protocols in Stem Cell Biology 55:1.
Crossref
Crossref
Rachel L. Manthe, Maximilian Loeck, Tridib Bhowmick, Melani Solomon & Silvia Muro. (2020) Intertwined mechanisms define transport of anti-ICAM nanocarriers across the endothelium and brain delivery of a therapeutic enzyme. Journal of Controlled Release 324, pages 181-193.
Crossref
Crossref
Xun Bao, Jianmei Wu, Youming Xie, Seongho Kim, Sharon Michelhaugh, Jun Jiang, Sandeep Mittal, Nader Sanai & Jing Li. (2019) Protein Expression and Functional Relevance of Efflux and Uptake Drug Transporters at the Blood–Brain Barrier of Human Brain and Glioblastoma. Clinical Pharmacology & Therapeutics 107:5, pages 1116-1127.
Crossref
Crossref
Annalise Di Marco, Domenico Vignone, Odalys Gonzalez Paz, Ivan Fini, Maria Rosaria Battista, Antonella Cellucci, Elena Bracacel, Giulio Auciello, Maria Veneziano, Vinod Khetarpal, Mark Rose, Alessandro Rosa, Isabelle Gloaguen, Edith Monteagudo, Todd Herbst, Celia Dominguez & Ignacio Muñoz-Sanjuán. (2020) Establishment of an in Vitro Human Blood-Brain Barrier Model Derived from Induced Pluripotent Stem Cells and Comparison to a Porcine Cell-Based System. Cells 9:4, pages 994.
Crossref
Crossref
Ana P. Spencer, Marília Torrado, Beatriz Custódio, Sara C. Silva-Reis, Sofia D. Santos, Victoria Leiro & Ana P. Pêgo. (2020) Breaking Barriers: Bioinspired Strategies for Targeted Neuronal Delivery to the Central Nervous System. Pharmaceutics 12:2, pages 192.
Crossref
Crossref
Daniel Chavarria, Carlos Fernandes, Vera Silva, Catia Silva, Eva Gil-Martins, Pedro Soares, Tiago Silva, Renata Silva, Fernando Remião, Paulo J. Oliveira & Fernanda Borges. (2020) Design of novel monoamine oxidase-B inhibitors based on piperine scaffold: Structure-activity-toxicity, drug-likeness and efflux transport studies. European Journal of Medicinal Chemistry 185, pages 111770.
Crossref
Crossref
Miguel Pinto, Sofia Benfeito, Carlos Fernandes & Fernanda Borges. 2020. Oxidative Stress and Dietary Antioxidants in Neurological Diseases. Oxidative Stress and Dietary Antioxidants in Neurological Diseases
125
141
.
Ina Puscas, Florian Bernard-Patrzynski, Martin Jutras, Marc-André Lécuyer, Lyne Bourbonnière, Alexandre Prat, Grégoire Leclair & V. Gaëlle Roullin. (2019) IVIVC Assessment of Two Mouse Brain Endothelial Cell Models for Drug Screening. Pharmaceutics 11:11, pages 587.
Crossref
Crossref
Sadhana Jackson, Caitlin Meeks, Amélie Vézina, Robert W. Robey, Kandice Tanner & Michael M. Gottesman. (2019) Model systems for studying the blood-brain barrier: Applications and challenges. Biomaterials 214, pages 119217.
Crossref
Crossref
Miguel Pinto, Carlos Fernandes, Eva Martins, Renata Silva, Sofia Benfeito, Fernando Cagide, Ricardo F. Mendes, Filipe A. Almeida Paz, Jorge Garrido, Fernando Remião & Fernanda Borges. (2019) Boosting Drug Discovery for Parkinson’s: Enhancement of the Delivery of a Monoamine Oxidase-B Inhibitor by Brain-Targeted PEGylated Polycaprolactone-Based Nanoparticles. Pharmaceutics 11:7, pages 331.
Crossref
Crossref
Annalise Di Marco, Odalys Gonzalez Paz, Ivan Fini, Domenico Vignone, Antonella Cellucci, Maria Rosaria Battista, Giulio Auciello, Laura Orsatti, Matteo Zini, Edith Monteagudo, Vinod Khetarpal, Mark Rose, Celia Dominguez, Todd Herbst, Leticia Toledo-Sherman, Vincenzo Summa & Ignacio Muñoz-Sanjuán. (2019) Application of an in Vitro Blood–Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington’s Disease. Molecular Pharmaceutics 16:5, pages 2069-2082.
Crossref
Crossref
Patrick E. Trapa, Matthew D. Troutman, Thomas Y. Lau, Travis T. Wager, Tristan S. Maurer, Nandini C. Patel, Mark A. West, John P. Umland, Anthony A. Carlo, Bo Feng & Jennifer L. Liras. (2019) In Vitro–In Vivo Extrapolation of Key Transporter Activity at the Blood–Brain Barrier. Drug Metabolism and Disposition 47:4, pages 405-411.
Crossref
Crossref
Fabien Plisson & Andrew Piggott. (2019) Predicting Blood–Brain Barrier Permeability of Marine-Derived Kinase Inhibitors Using Ensemble Classifiers Reveals Potential Hits for Neurodegenerative Disorders. Marine Drugs 17:2, pages 81.
Crossref
Crossref
Frederick R. Taylor. (2019) CGRP, Amylin, Immunology, and Headache Medicine. Headache: The Journal of Head and Face Pain 59:1, pages 131-150.
Crossref
Crossref
Bhupesh Sharma, Kanishk Luhach & G.T. Kulkarni. 2019. Brain Targeted Drug Delivery System. Brain Targeted Drug Delivery System
53
101
.
Fernanda Rodriguez‐Otormin, Aroa Duro‐Castano, Inmaculada Conejos‐Sánchez & María J. Vicent. (2018) Envisioning the future of polymer therapeutics for brain disorders. WIREs Nanomedicine and Nanobiotechnology 11:1.
Crossref
Crossref
Judie B. Alimonti, Maria Ribecco-Lutkiewicz, Caroline Sodja, Anna Jezierski, Danica B. Stanimirovic, Qing Liu, Arsalan S. Haqqani, Wayne Conlan & Mahmud Bani-Yaghoub. (2018) Zika virus crosses an in vitro human blood brain barrier model. Fluids and Barriers of the CNS 15:1.
Crossref
Crossref
Qin Wang, Luisette Delva, Paul H. Weinreb, Robert B. Pepinsky, Danielle Graham, Elvana Veizaj, Anne E. Cheung, Weiping Chen, Ivan Nestorov, Ellen Rohde, Robin Caputo, Geoffrey M. Kuesters, Tonika Bohnert & Liang-Shang Gan. (2018) Monoclonal antibody exposure in rat and cynomolgus monkey cerebrospinal fluid following systemic administration. Fluids and Barriers of the CNS 15:1.
Crossref
Crossref
Elena D. Osipova, Yulia K. Komleva, Andrey V. Morgun, Olga L. Lopatina, Yulia A. Panina, Raissa Ya. Olovyannikova, Elizaveta F. Vais, Vladimir V. Salmin & Alla B. Salmina. (2018) Designing in vitro Blood-Brain Barrier Models Reproducing Alterations in Brain Aging. Frontiers in Aging Neuroscience 10.
Crossref
Crossref
Hassan Pezeshgi Modarres, Mohsen Janmaleki, Mana Novin, John Saliba, Fatima El-Hajj, Mahdi RezayatiCharan, Amir Seyfoori, Hamid Sadabadi, Milène Vandal, Minh Dang Nguyen, Anwarul Hasan & Amir Sanati-Nezhad. (2018) In vitro models and systems for evaluating the dynamics of drug delivery to the healthy and diseased brain. Journal of Controlled Release 273, pages 108-130.
Crossref
Crossref
Maria Ribecco-Lutkiewicz, Caroline Sodja, Julie Haukenfrers, Arsalan S. Haqqani, Dao Ly, Peter Zachar, Ewa Baumann, Marguerite Ball, Jez Huang, Marina Rukhlova, Marzia Martina, Qing Liu, Danica Stanimirovic, Anna Jezierski & Mahmud Bani-Yaghoub. (2018) A novel human induced pluripotent stem cell blood-brain barrier model: Applicability to study antibody-triggered receptor-mediated transcytosis. Scientific Reports 8:1.
Crossref
Crossref
Tori B. Terrell-Hall, Amanda G. Ammer, Jessica I. G. Griffith & Paul R. Lockman. (2017) Permeability across a novel microfluidic blood-tumor barrier model. Fluids and Barriers of the CNS 14:1.
Crossref
Crossref
David E Watson, Rosemarie Hunziker & John P Wikswo. (2017) Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology. Experimental Biology and Medicine 242:16, pages 1559-1572.
Crossref
Crossref
Paul Curley, Marco Giardiello, Neill J. Liptrott, David Dickens, Darren M. Moss, James J. Hobson, Alison C. Savage, Tom O. McDonald, Marco Siccardi, Steve Rannard & Andrew Owen. (2017) In vitro characterisation of solid drug nanoparticle compositions of efavirenz in a brain endothelium cell line. Journal of Interdisciplinary Nanomedicine 2:3, pages 157-169.
Crossref
Crossref
Mukta Agrawal, Ajazuddin, Dulal K. Tripathi, Swarnlata Saraf, Shailendra Saraf, Sophia G. Antimisiaris, Spyridon Mourtas, Margareta Hammarlund-Udenaes & Amit Alexander. (2017) Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease. Journal of Controlled Release 260, pages 61-77.
Crossref
Crossref
Yumi Yamamoto, Meindert Danhof & Elizabeth C. M. de Lange. (2017) Microdialysis: the Key to Physiologically Based Model Prediction of Human CNS Target Site Concentrations. The AAPS Journal 19:4, pages 891-909.
Crossref
Crossref
Asli Kara, Naile Ozturk & Imran Vural. 2017. Nanotechnology Methods for Neurological Diseases and Brain Tumors. Nanotechnology Methods for Neurological Diseases and Brain Tumors
151
185
.
Song Guo, Anne L.H. Vollesen, Jes Olesen & Messoud Ashina. (2016) Premonitory and nonheadache symptoms induced by CGRP and PACAP38 in patients with migraine. Pain 157:12, pages 2773-2781.
Crossref
Crossref
Carla L. Esposito, Silvia Nuzzo, Swati A. Kumar, Anna Rienzo, Clare L. Lawrence, Roberto Pallini, Lisa Shaw, Jane E. Alder, Lucia Ricci-Vitiani, Silvia Catuogno & Vittorio de Franciscis. (2016) A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells. Journal of Controlled Release 238, pages 43-57.
Crossref
Crossref
Martin Raasch, Knut Rennert, Tobias Jahn, Claudia Gärtner, Gilbert Schönfelder, Otmar Huber, Andrea E. M. Seiler & Alexander S. Mosig. (2016)
An integrative microfluidically supported
in vitro
model of an endothelial barrier combined with cortical spheroids simulates effects of neuroinflammation in neocortex development
. Biomicrofluidics 10:4.
Crossref
Crossref
Ravi K Sajja, Shafiqur Rahman & Luca Cucullo. (2015) Drugs of abuse and blood-brain barrier endothelial dysfunction: A focus on the role of oxidative stress. Journal of Cerebral Blood Flow & Metabolism 36:3, pages 539-554.
Crossref
Crossref
Norman R. Saunders, Mark D. Habgood, Kjeld Møllgård & Katarzyna M. Dziegielewska. (2016) The biological significance of brain barrier mechanisms: help or hindrance in drug delivery to the central nervous system?. F1000Research 5, pages 313.
Crossref
Crossref
Marcelo E Bigal, David W Dodick, Alan M Rapoport, Stephen D Silberstein, Yuju Ma, Ronghua Yang, Pippa S Loupe, Rami Burstein, Lawrence C Newman & Richard B Lipton. (2015) Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study. The Lancet Neurology 14:11, pages 1081-1090.
Crossref
Crossref
Marcelo E Bigal, Lars Edvinsson, Alan M Rapoport, Richard B Lipton, Egilius L H Spierings, Hans-Christoph Diener, Rami Burstein, Pippa S Loupe, Yuju Ma, Ronghua Yang & Stephen D Silberstein. (2015) Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study. The Lancet Neurology 14:11, pages 1091-1100.
Crossref
Crossref
Jacquelyn A. Brown, Virginia Pensabene, Dmitry A. Markov, Vanessa Allwardt, M. Diana Neely, Mingjian Shi, Clayton M. Britt, Orlando S. Hoilett, Qing Yang, Bryson M. Brewer, Philip C. Samson, Lisa J. McCawley, James M. May, Donna J. Webb, Deyu Li, Aaron B. Bowman, Ronald S. Reiserer & John P. Wikswo. (2015) Recreating blood-brain barrier physiology and structure on chip: A novel neurovascular microfluidic bioreactor. Biomicrofluidics 9:5.
Crossref
Crossref